Henlius Aims to Launch More Biosimilars in US, EU
Jason Zhu Jun, Executive Director and CEO of Chinese drugmaker Shanghai Henlius Biotech, says the Hong Kong-listed firm is gaining…
Jason Zhu Jun, Executive Director and CEO of Chinese drugmaker Shanghai Henlius Biotech, says the Hong Kong-listed firm is gaining…